EFFECT OF TOREMIFENE IN BREAST-CANCER PATIENTS - PRELIMINARY COMMUNICATION

被引：9
|
作者：
HINDY, I
JUHOS, E
SZANTO, J
SZAMEL, I
机构：
[1] National Institute of Oncology, 1525 Budapest
来源：
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 1990年 / 36卷 / 03期
关键词：
D O I：
10.1016/0022-4731(90)90010-P
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Toremifene, an antiestrogenic drug administered at three dose levels (60, 120, and 300 mg/day) was investigated in 17 postmenopausal patients with advanced breast cancer previously treated with hormonal and/or cytostatic therapy. The drug proved to be well tolerated at all dose levels without any serious side effects even on prolonged administration. Neither response nor side effects have shown any dose dependency in this small group of patients. © 1990.
引用
收藏
页码：225 / 226
页数：2
相关论文
共 50 条
  • [1] PHASE-II CLINICAL-STUDY OF TOREMIFENE IN PATIENTS WITH METASTATIC BREAST-CANCER - PRELIMINARY COMMUNICATION
    MODIG, H
    BORGSTROM, S
    NILSSON, I
    WESTMAN, G
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 36 (03): : 235 - 236
  • [2] RESPONSE TO TOREMIFENE (FC-1157A) THERAPY IN TAMOXIFEN FAILED PATIENTS WITH BREAST-CANCER - PRELIMINARY COMMUNICATION
    EBBS, SR
    ROBERTS, J
    BAUM, M
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 36 (03): : 239 - 239
  • [3] HORMONAL EFFECTS OF TOREMIFENE IN BREAST-CANCER PATIENTS
    SZAMEL, I
    VINCZE, B
    HINDY, I
    KERPELFRONIUS, S
    ECKHARDT, S
    MAENPAA, J
    GRONROOS, M
    KANGAS, L
    SUNDQUIST, H
    HAJBA, A
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 36 (03): : 243 - 247
  • [4] TREATMENT OF ADVANCED BREAST-CANCER WITH 20 MG TOREMIFENE, A PHASE-II STUDY - PRELIMINARY COMMUNICATION
    PYRHONEN, S
    VALAVAARA, R
    HEIKKINEN, M
    RISSANEN, P
    BLANCO, G
    NORDMAN, E
    HOLSTI, LR
    HAJBA, A
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 36 (03): : 227 - 228
  • [5] INFLUENCE OF TOREMIFENE ON THE ENDOCRINE REGULATION IN BREAST-CANCER PATIENTS
    SZAMEL, I
    HINDY, I
    VINCZE, B
    ECKHARDT, S
    KANGAS, L
    HAJBA, A
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (02) : 154 - 158
  • [6] PHARMACOKINETICS OF TOREMIFENE AND ITS METABOLITES IN PATIENTS WITH ADVANCED BREAST-CANCER
    WIEBE, VJ
    BENZ, CC
    SHEMANO, I
    CADMAN, TB
    DEGREGORIO, MW
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 25 (04) : 247 - 251
  • [7] THE EFFECT OF TOREMIFENE THERAPY ON SERUM IMMUNOGLOBULIN LEVELS IN BREAST-CANCER
    PAAVONEN, T
    ARONEN, H
    PYRHONEN, S
    HAJBA, A
    ANDERSSON, LC
    APMIS, 1991, 99 (09) : 849 - 853
  • [8] TOREMIFENE, A TRIPHENYLETHYLENE ANTIESTROGEN, FOR THE TREATMENT OF BREAST-CANCER
    VALAVAARA, R
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1992, 71 (03) : 249 - 250
  • [9] BREAST-CANCER - PATIENT CHOICE OF TREATMENT - PRELIMINARY COMMUNICATION
    ASHCROFT, JJ
    LEINSTER, SJ
    SLADE, PD
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1985, 78 (01) : 43 - 46
  • [10] PREOPERATIVE ASSESSMENT AND STAGING OF BREAST-CANCER - PRELIMINARY COMMUNICATION
    FORREST, APM
    BLACK, RB
    HUMENIUK, V
    CANT, ELM
    HAWKINS, RA
    PRESCOTT, RJ
    ROBERTS, MM
    SHIVAS, AA
    STEWART, HJ
    SMITH, AF
    SUMERLING, M
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1980, 73 (08) : 561 - 566
12345